Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15
Impact in
- Oncology 456
- Immunology 247
Classified as
- Journal
- Nature Medicine
In The Last Decade
doi.org/10.1038/nm827 →Countries where authors are citing Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15
This map shows the geographic impact of Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15 with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15 more than expected).
Fields of papers citing Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15
This network shows the impact of Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.
About Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15
This paper, published in 2003, received 517 indexed citations . Written by Renier J. Brentjens, Jean‐Baptiste Latouche, Elmer Santos, Francesc Martí, Michael Gong, Clay Lyddane, Philip D. King, Steven M. Larson, Mark A. Weiss and Isabelle Rivière covering the research area of Immunology and Oncology. It is primarily cited by scholars working on Oncology (456 citations), Immunology (247 citations), Genetics (146 citations), Molecular Biology (128 citations) and Biomedical Engineering (92 citations). Published in Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1038/nm827.